首页> 外文期刊>Annals of hematology >High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia.
【24h】

High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia.

机译:Ets相关基因(ERG)的高表达是急性早幼粒细胞白血病患者无复发生存的独立预后标志物。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In acute promyelocytic leukemia (APL), relapse occurs in about 15 % of cases and is a major cause for death. Molecular markers identifying patients at high risk for relapse are not well established. High expression of the transcription factor Ets-related gene (ERG) is associated with inferior overall survival (OS) and disease-free survival in different types of hematologic malignancies. There are no data available about the impact of ERG expression in APL. ERG expression levels were analyzed in bone marrow samples of 86 APL patients at initial diagnosis. High ERG expression was significantly associated with an inferior OS in patients who had reached first complete remission. It was also significantly correlated with inferior relapse-free survival (RFS) and time to relapse (i.e., relapse-free interval, RFI). In multivariate analysis, high ERG expression had an independent negative impact on RFS and RFI. High ERG expression was significantly associated with inferior OS, RFS, and RFI. Moreover, in multivariate analysis, it maintained its value as an independent negative prognostic factor with regard to RFS and RFI. Therefore, ERG expression might serve as a molecular marker for risk stratification in APL and might identify patients who could benefit from intensified treatment regimens.
机译:在急性早幼粒细胞白血病(APL)中,约15%的病例会复发,这是导致死亡的主要原因。不能确定识别高复发风险患者的分子标记物。在不同类型的血液系统恶性肿瘤中,转录因子Ets相关基因(ERG)的高表达与较低的总体生存率(OS)和无病生存率相关。没有有关ERG表达在APL中的影响的数据。初步诊断时,分析了86名APL患者的骨髓样本中的ERG表达水平。首次完全缓解的患者,ERG的高表达与OS低劣显着相关。它也与较低的无复发生存期(RFS)和复发时间(即无复发间隔RFI)密切相关。在多变量分析中,高ERG表达对RFS和RFI具有独立的负面影响。高ERG表达与OS,RFS和RFI较差有关。此外,在多变量分析中,它保持了其作为RFS和RFI的独立阴性预后因素的价值。因此,ERG的表达可能作为APL中风险分层的分子标记,并可能识别出可以从强化治疗方案中受益的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号